We've got an exciting role coming up soon!
We're looking for someone with excellent organisational and problem-solving skills to join our Global Challenges Programme.
Think this could be be you? Find out more here: https://t.co/ZSYjxQaUI5
#reubenroles#workwithus#hiring
Applications for our DPhil programme are still open!
We held an Open Day to show prospective students why we think the Institute is a special place to do your #PhD - with tours, taster lectures and technology showcases. Read about it here! ⬇️
https://t.co/jDaicrAFOc
NEWS: Cellular roadmap reveals new paths to treating inflammatory bowel disease
Researchers at @KirOxford have mapped the cellular dynamics following the most commonly used advanced therapy in autoimmune diseases, potentially allowing for new therapies
https://t.co/aCjK936Dm0
Why do some inflammatory bowel disease patients benefit from anti-TNF therapy whilst others do not?
Our new @NatImmunol resource paper investigates this question by following patients before and after treatment: https://t.co/AmOpIBwqjB 👇
10/ And a shout-out to Matthias Friedrich, Mathilde Pohin, Devika Agarwal @deevdevil, & Charlotte Rich-Griffin for their excellent contributions - & with thanks to the Celsius team, @ColesBuckleyLab, @powrie_lab, & @a_filer & all co-authors!!